Omeros Corp. (OMER)
10.59
-0.65
(-5.78%)
USD |
NASDAQ |
Dec 11, 16:00
10.91
+0.32
(+3.02%)
After-Hours: 04:47
Omeros Free Cash Flow: -105.32M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.917B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| GeoVax Labs, Inc. | -24.29M |
| Vistagen Therapeutics, Inc. | -53.96M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.47M |
| Cash from Investing (Quarterly) | -6.861M |
| Cash from Financing (Quarterly) | 25.82M |
| Free Cash Flow Per Share (Quarterly) | -0.2789 |
| Free Cash Flow to Equity (Quarterly) | 0.088M |
| Free Cash Flow to Firm (Quarterly) | -18.48M |
| Free Cash Flow Yield | -16.51% |